MAM
Amagi Media to tie up with 5 broadcasters
KOLKATA: Amagi Media Labs is gearing to increase its reach. The Bengaluru based technology and media startup that facilitates geo-targeting of television advertisements, is now expanding its services to five more national broadcasters. And all this in the next two-three months.
“We are in discussions with broadcasters who have presence largely in the Hindi speaking markets (HSM),” informed Amagi Media Labs business head LS Krishnan.
Amagi had recently roped in Zee Media as a broadcast partner and in turn added Zee News and Zee Business to its channel roster. “IBN7, CNBC Awaz, Times Now and UTV Movies, among others are our partners,” he said.
The company is also looking at getting the fourth round of private equity funding. “We have signed the paper and expect the funds flowing in the company, anytime sooner,” added Krishnan, without divulging any detail on the amount to be infused in Amagi for further expansion of business.
Krishnan who was addressing the press in Kolkata, stressed on the eastern region becoming an important destination for national brands. “The region is important for brands that are looking for deeper penetration and reach. 45 per cent of viewers in West Bengal are Hindi speaking. The region contributes around 20-25 per cent to our topline. We aim to scale up in terms of advertisers here,” he said.
Currently, Amagi has around 50 clients in the state. Some of which are: Shalimar, Konark Cement and Keo Karpin. “80 per cent of the revenue comes from the FMCG sector,” concluded Krishnan.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
